✦ LIBER ✦

Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia

✍ Scribed by Anderson, K. R.; Chambers, C. R.; Lam, N.; Yau, P. S.; Cusano, F.; Savoie, M. L.; Sheikh, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-line treatment for chronic myeloid

✍ Guoqing Wei; Shamudheen Rafiyath; Delong Liu 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 298 KB

Major molecular response during the firs

✍ Signorovitch, James; Ayyagari, Rajeev; Reichmann, William M.; Wu, Eric Q.; Chen, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 406 KB

A retrospective analysis of therapy adhe

✍ Guérin, Annie; Chen, Lei; Wu, Eric Q.; Ponce de Leon, Diego; Griffin, James D. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 174 KB

When Evaluating Parameter Uncertainty Is

✍ Shelby D. Reed 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

The relative efficacy of imatinib, dasat

✍ Stuart Mealing,Leticia Barcena,Neil Hawkins… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 309 KB

PCN63 The Relative Value of Dasatinib Ve

✍ L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB